Results 91 to 100 of about 7,188,138 (247)

CT radiomics based model for differentiating malignant and benign small (≤20mm) solid pulmonary nodules

open access: yesFrontiers in Oncology
BackgroundCurrently, the computed tomography (CT) radiomics-based models, which can evaluate small (≤ 20 mm) solid pulmonary nodules (SPNs) are lacking.
Jing-Xi Sun   +6 more
doaj   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

open access: yesMolecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath   +13 more
wiley   +1 more source

Analysis of Project Success Factors and Project Success Criteria in Micro and Small Firms: Evidence from Slovenia

open access: yesOrganizacija
The aim of this paper is to examine the use of project management practices in Slovenian micro and small firms (MSFs) and to identify project success factors (SF) and project success criteria (SC).
Gošnik Dušan   +2 more
doaj   +1 more source

Review of small bowel capsule endoscopy for diagnosis of gastrointestinal bleeding

open access: yesInternational Journal of Gastrointestinal Intervention
Capsule endoscopy (CE), introduced in 2001, is now a key tool for evaluating small-bowel bleeding, which accounts for 5% to 10% of gastrointestinal (GI) bleeding.
Dong Jun Oh
doaj   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

open access: yesMolecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak   +8 more
wiley   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

EFFECT OF TRAINING ON TECHNICAL SKILLS AMONG MID-LEVEL EMPLOYEES IN SMALL SCALE MSME ORGANIZATION

open access: yesICTACT Journal on Management Studies
This research aims to assess the impact of a specialized training program on the enhancement of technical skills among mid-level employees within small-scale Micro, Small, and Medium Enterprises (MSMEs).
Anil Kumar Yadav, Mithilesh Tiwari
doaj   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

open access: yesMolecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy